冠昊生物

300238 SZSE 证监会行业分类 C35专用设备制造业

Key Metrics

Market Cap

4.1B ($591.9M)

P/E Ratio

N/A

P/B Ratio

N/A

Revenue

377.0M

Net Income

16.6M

Gross Margin

N/A

Op. Margin

7.5%

Net Margin

4.4%

ROE

3.5%

ROA

2.2%

D/E

0.61

Dividend Yield

N/A

EPS

0.10

Current Ratio

1.49

Price History

Company Info

Industry	C35专用设备制造业
Market Segment	ChiNext
Currency	CNY
Fiscal Year	2024

Business Overview

Full Financials Advanced Charts Filings

Peers

工商银行

601398

2.7T

P/E: 7.6

建设银行

601939

2.5T

P/E: 7.2

农业银行

601288

2.4T

P/E: 8.7

中国海油

600938

2.0T

P/E: 16.2

宁德时代

300750

1.9T

P/E: 25.6

贵州茅台

600519

1.8T

P/E: 20.1

中国银行

601988

1.8T

P/E: 7.3

中国人寿

601628

1.2T

P/E: 6.9

Financial Statements

Loading financials...

Open Advanced Charts

Full charting with technical indicators, candlestick, and more.

About 冠昊生物

Guanhao Biotech Co.,Ltd. develops, manufactures, and sells regenerative medicines and life sciences products primarily in China. It offers NormalGEN, a dura repair patch; GrandNeuro, a dura repair patch; ThormalGEN, a surgical patch; DermalGEN, a wound dressing product; IREAL breast patch; and Youvision corneal graft, as well as license in intraocular lenses. The company also provides Biological dura, a spinal patch; Type B dura, a spinal patch; Sterile Bio Wound Membrane; Ario Mesh; Thoracic Surgery Repair Diaphragm; and Cympic Benvimod Cream for psoriasis. In addition, it offers artificial lens and medical instruments; and cell technology services. Its products can be used in neurosurgery, thoracic general surgery, ophthalmology, dermatology, orthopedics, cosmetology, plastic surgery, and other areas. Guanhao Biotech Co.,Ltd. was founded in 1999 and is headquartered in Guangzhou, China.

Ticker	300238
Exchange	SZSE
Sector	证监会行业分类
Industry	C35专用设备制造业